Profil Financier
Cao Longxiang & family occupe actuellement le rang #1454 du classement mondial StarFortune (secteur santé & biotech). Fortune nette estimée : $2.9 B (+$285 sur 24h).
Cao Longxiang chairs Hubei Jumpcan Pharmaceutical, one of China's largest drug companies, specializing in both western and traditional Chinese medicine.
Cao's son, Cao Fei, serves as the company's vice chairman.
The company went public in 2001 as Hubei Hongcheng General Machinery, before Cao took control in 2013; he now owns more than 60% of the company.
Cao was a manager at a cement factory before taking a job with Hubei and served in the Chinese military before entering the pharma business.